fomesafen has been researched along with sq-11725 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolla, G; Giannattasio, C; Grassi, G; Mancia, G; Parati, G; Pomidossi, G; Sabadini, E; Zanchetti, A | 1 |
| Barg, AP; Bernstein, KN; O'Connor, DT | 1 |
1 review(s) available for fomesafen and sq-11725
| Article | Year |
|---|---|
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Cardiovascular Physiological Phenomena; Cardiovascular System; Celiprolol; Heart Rate; Humans; Hypertension; Nadolol; Phenylephrine; Pressoreceptors; Propanolamines; Reflex | 1986 |
1 trial(s) available for fomesafen and sq-11725
| Article | Year |
|---|---|
Nadolol: evidence for sympathetic nerve inhibition by a beta blocker in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atropine; Blood Pressure; Humans; Hypertension; Male; Middle Aged; Nadolol; Nitrates; Pentanols; Phentolamine; Phenylephrine; Pressoreceptors; Propanolamines; Reflex; Sympathetic Nervous System | 1983 |